{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:30:33Z","timestamp":1759991433340},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"S7","license":[{"start":{"date-parts":[[1991,7,1]],"date-time":"1991-07-01T00:00:00Z","timestamp":678326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1991,7]]},"DOI":"10.1007\/bf01715829","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T11:01:43Z","timestamp":1118574103000},"page":"S365-S371","source":"Crossref","is-referenced-by-count":5,"title":["Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens"],"prefix":"10.1007","volume":"19","author":[{"given":"C.","family":"Chidiac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01715829_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM198607173150305","volume":"315","author":"J. T. Grayston","year":"1986","unstructured":"Grayston, J. T., Kuo, C. C., Wang, S. P., Altman, J. P. A newChlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N. Engl. J. Med. 315 (1986) 161\u2013168.","journal-title":"N. Engl. J. Med."},{"key":"BF01715829_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005792-199009000-00004","volume":"69","author":"G. D. Fang","year":"1990","unstructured":"Fang, G. D., Fine, M., Orloff, J., Arisumi, D., Yu, V. C., Kapoor, W., Grayston, J. T., Wang, S. P., Kohler, R., Muder, R. R., Yee, Y. C., Rihs, J. D., Vickers, B. S. New and emerging etiologies for community acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69 (1990) 307\u2013316.","journal-title":"Medicine"},{"issue":"Suppl. C","key":"BF01715829_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/22.Supplement_C.9","volume":"22","author":"R. N. Gr\u00fcneberg","year":"1988","unstructured":"Gr\u00fcneberg, R. N., Felmigham, D., O'Hare, M. D., Robbins, M. J., Perry, K., Wall, R. A., Ridgway, G. L. The comparativein vitro activity of ofloxacin. J. Antimicrob. Chemother. 22 (Suppl. C) (1988) 9\u201319.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01715829_CR4","unstructured":"Garcia-de-Lomas, J., Munoz, C., Escoms, R., Valls, A., Calpagi: Activity of temafloxacin in comparison with other fluoroquinolones againstLegionella pneumophila. 3rd International Symposium on New Quinolones, Vancouver, Canada, July 12\u201314, 1990, Abstract no. 71."},{"key":"BF01715829_CR5","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.31.11.1768","volume":"31","author":"D. J. Hardy","year":"1987","unstructured":"Hardy, D. J., Swanson, R. N., Hensey, D. M., Ramer, N. R., Bower, R. R., Hanson, C. W., Chu, D. T. W., Fernandes, P. B. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. Antimicrob. Agents Chemother. 31 (1987) 1768\u20131774.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR6","first-page":"496","volume":"36","author":"H. Renaudin","year":"1988","unstructured":"Renaudin, H., Quentin, L., De Barbeyrac, B., Bebear, C. Activit\u00e9in vitro de nouvelles quinolones sur les Mycoplasmes pathog\u00e8nes pour l'homme. Pathol. Biol. 36 (1988) 496\u2013499.","journal-title":"Pathol. Biol."},{"key":"BF01715829_CR7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0732-8893(89)90115-6","volume":"12","author":"G. H. Cassell","year":"1989","unstructured":"Cassell, G. H., Waites, K. B., Pate, M. S., Canupp, K. C., Duffy, L. B. Comparative susceptibility ofMycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin. Diagn. Microbiol. Infect. Dis. 12 (1989) 433\u2013435.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"BF01715829_CR8","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.32.10.1500","volume":"32","author":"K. B. Waites","year":"1988","unstructured":"Waites, K. B., Cassell, G. H., Canupp, K. C., Fernandes, P. B. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and Aryl fluoroquinolones. Antimicrob. Agents Chemother. 32 (1988) 1500\u20131502.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/AAC.23.3.509","volume":"23","author":"Y. Osada","year":"1983","unstructured":"Osada, Y., Ogawa, H. Antimycoplasmal activity of ofloxacin. Antimicrob. Agents Chemother. 23 (1983) 509\u2013511.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/AAC.23.5.641","volume":"23","author":"S. Nakamura","year":"1983","unstructured":"Nakamura, S., Minami, A., Katae, H., Yamagishi, S., Takase, Y., Shimizu, M. In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob. Agents Chemother. 23 (1983) 641\u2013648.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR11","volume-title":"In vitro susceptibility ofChlamydia pneumoniae (strain IOL 207) against a new fluoroquinolone, sparfloxacin, compared to different other molecules","author":"J. Orfila","year":"1990","unstructured":"Orfila, J., Haider, F., Eb, F. In vitro susceptibility ofChlamydia pneumoniae (strain IOL 207) against a new fluoroquinolone, sparfloxacin, compared to different other molecules. In: Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21\u201324, 1990. American Society for Microbiology, Washington D.C. 1990, Abstract no. 18."},{"key":"BF01715829_CR12","unstructured":"Hyman, C. L., Roblin, P. T., Hammerschlag, M. R.: In vitro activity of sparfloxacin (C1978-AT-4140), a novel quinolone, ofloxacin and fleroxacin againstChlamydia pneumoniae. 3rd International Symposium on New Quinolones, Vancouver, Canada, July 12\u201314, 1990, Abstract no. 70."},{"key":"BF01715829_CR13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/AAC.33.9.1634","volume":"33","author":"K. Chirgwin","year":"1989","unstructured":"Chirgwin, K., Roblin, P. M., Hammerschlag, M. R. In vitro susceptibilities ofChlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob. Agents Chemother. 33 (1989) 1634\u20131635.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR14","volume-title":"In vitro activity of sparfloxacin and two other quinolones againstChlamydia trachomatis andChlamydia pneumoniae","author":"P. M. Roblin","year":"1990","unstructured":"Roblin, P. M., Hammerschlag, M. R. In vitro activity of sparfloxacin and two other quinolones againstChlamydia trachomatis andChlamydia pneumoniae. In: Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21\u201324, 1990. American Society for Microbiology, Washington D. C. 1990, Abstract no. 22."},{"issue":"Suppl. C","key":"BF01715829_CR15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/22.Supplement_C.91","volume":"22","author":"J. Symonds","year":"1988","unstructured":"Symonds, J., Javaid, A., Bone, M., Turner, A. The penetration of ofloxacin into bronchial secretions. J. Antimicrob. Chemother. 22 (Suppl. C) (1988) 91\u201396.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01715829_CR16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/jac\/27.3.335","volume":"27","author":"P. G. Davey","year":"1981","unstructured":"Davey, P. G., Precious, E., Winter, J. H. Bronchial penetration of ofloxacin after single and multiple oral dosage. J. Antimicrob. Chemother. 27 (1981) 335\u2013341.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. 1","key":"BF01715829_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003495-198700341-00009","volume":"34","author":"L. Courard","year":"1987","unstructured":"Courard, L., Fourtillan, J. B., Saux, M. C., Bryskier, A., Vincent-du-Laurier, M. Diffusion of ofloxacin into human lung tissue. Drugs 34 (Suppl. 1) (1987) 37\u201338.","journal-title":"Drugs"},{"issue":"Suppl. C","key":"BF01715829_CR18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/22.Supplement_C.85","volume":"22","author":"W. J. A. Wijnands","year":"1988","unstructured":"Wijnands, W. J. A., Vree, T. B., Baars, A. M., Hafkenscheid, J. C. M., Kohler, B. E. M., Van Herwaarden, C. L. A. J. Antimicrob. Chemother. 22 (Suppl. C) (1988) 85\u201390.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01715829_CR19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/AAC.35.2.380","volume":"35","author":"F. Serour","year":"1991","unstructured":"Serour, F., Dan, M., Gorca, A., Yellin, A., Lieberman, Y., Berger, S. Penetration of ofloxacin into human lung tissue following a single oral dose of 200 milligrams. Antimicrob. Agents Chemother. 35 (1991) 380\u2013381.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR20","first-page":"189","volume-title":"The new generation of quinolones","author":"J. Schentag","year":"1990","unstructured":"Schentag, J., Wise, R., Nix, D. E. Pharmacokinetics and tissue penetration of quinolones. In:Siporin, C., Heifetz, C. L., Domagala, J. M. (eds): The new generation of quinolones. Marcel Dekker, New York 1990, pp. 189\u2013222."},{"issue":"Suppl. B","key":"BF01715829_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/26.suppl_B.27","volume":"26","author":"M. B. Carlier","year":"1990","unstructured":"Carlier, M. B., Sorneaux, B., Zenebergh, A., Desnottes, J. F., Tulkens, P. M. Cellular uptake, localization and activity of fluoroquinolones in infected macrophages. J. Antimicrob. Chemother. 26 (Suppl. B) (1990) 27\u201339.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. 5","key":"BF01715829_CR22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/clinids\/11.Supplement_5.S979","volume":"11","author":"J. J. Pocidalo","year":"1989","unstructured":"Pocidalo, J. J. Use of fluoroquinolones for intracellular pathogens. Rev. Infect. Dis. 11 (Suppl. 5) (1989) 979\u2013984.","journal-title":"Rev. Infect. Dis."},{"key":"BF01715829_CR23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jac\/27.3.343","volume":"27","author":"K. Kitsukawa","year":"1991","unstructured":"Kitsukawa, K., Hara, J., Saito, A. Inhibition ofLegionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents. J. Antimicrob. Chemother. 27 (1991) 343\u2013353.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. C","key":"BF01715829_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jac\/22.Supplement_C.53","volume":"22","author":"R. B. Fitzgeorge","year":"1988","unstructured":"Fitzgeorge, R. B., Featherstone, A. S. R., Baskerville, A. The effect of ofloxacin on the intracellular growth ofLegionella pneumophila in guinea pig alveolar phagocytes. J. Antimicrob. Chemother. 22 (Suppl. C) (1988) 53\u201357.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01715829_CR25","volume-title":"Inhibitory and postantibacterial effect of temafloxacin on virulentLegionella pneumophia","author":"P. Rajagopalan-Levasseur","year":"1990","unstructured":"Rajagopalan-Levasseur, P., Dameron, G., Forgue, M. F., Pocidalo, J. J. Inhibitory and postantibacterial effect of temafloxacin on virulentLegionella pneumophia. Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21\u201324, 1990. American Society for Microbiology, Washington D.C. 1990, Abstract no. 145."},{"key":"BF01715829_CR26","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1128\/AAC.34.9.1733","volume":"34","author":"P. Rajagopalan-Leveasseur","year":"1990","unstructured":"Rajagopalan-Leveasseur, P., Dournon, E., Dameron, G., Vilde, J. L., Pocidalo, J. J. Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication ofLegionella pneumophila serogroup 1. Antimicrob. Agents Chemother. 34 (1990) 1733\u20131738.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR27","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/AAC.33.7.1052","volume":"35","author":"M. R. Yeaman","year":"1989","unstructured":"Yeaman, M. R., Roman, M. J., Baca, O. G. Antibiotic susceptibilities of twoCoxiella burnetti isolates implicated in distinct clinical syndromes. Antimicrob. Agents Chemother. 35 (1989) 1052\u20131057.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.35.1.88","volume":"35","author":"D. Raoult","year":"1991","unstructured":"Raoult, D., Bres, P., Drancourt, M., Vestris, G. In vitro susceptibilities ofCoxiella burnetti, Rickettsia rickettsii andRickettsia conorii to the fluoroquinolone sparfloxacin. Antimicrob. Agents Chemother. 35 (1991) 88\u201391.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.31.7.1079","volume":"31","author":"M. R. Yeaman","year":"1987","unstructured":"Yeaman, M. R., Mitscher, L. A., Baca, O. G. In vitro susceptibility ofCoxiella burnetti to antibiotics including several quinolones. Antimicrob. Agents Chemother. 31 (1987) 1079\u20131084.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.28.1.15","volume":"28","author":"A. Saito","year":"1985","unstructured":"Saito, A., Sawatari, K., Fukuda, Y., Nagasawa, M., Koga, H., Tomonaga, A., Nakazato, H., Fujita, K., Shigeno, Y., Suzuyama, Y., Yamaguchi, K., Izumikawa, K., Hara, K. Susceptibility ofLegionella pneumophila to ofloxacinin vitro and in experimental legionella pneumonia in guinea pigs. Antimicrob. Agents Chemother. 28 (1985) 15\u201320.","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1B","key":"BF01715829_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/17.suppl_B.41","volume":"17","author":"E. Dournon","year":"1986","unstructured":"Dournon, E., Rajagopalan, P., Vilde, J. L., Pocidalo, J. J. Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis. J. Antimicrob. Chemother. 17 (Suppl. 1B) (1986) 41\u201348.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01715829_CR32","first-page":"39","volume-title":"Acquisitions R\u00e9centes sur les Nouvelles Quinolones","author":"E. Dournon","year":"1988","unstructured":"Dournon, E., Rajagopalan, P. Comparaison de l'activit\u00e9 de ciprofloxacine, ofloxacine et pefloxacine dans un modele animal d'infection \u00e0 legionella. In:Carbon, C., Pocidalo, J. J., Cremieux, A. C. (eds.): Acquisitions R\u00e9centes sur les Nouvelles Quinolones. Arnette, Paris 1988, pp. 39\u201343."},{"key":"BF01715829_CR33","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/AAC.34.11.2122","volume":"34","author":"P. H. Edelstein","year":"1990","unstructured":"Edelstein, P. H., Edelstein, M. A. C., Weidenfeld, J., Dorr, M. B. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs withL. pneumophila pneumonia. Antimicrob. Agents Chemother. 34 (1990) 2122\u20132127.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01715829_CR34","first-page":"1137","volume":"37","author":"C. Leroy","year":"1989","unstructured":"Leroy, C., Chidiac, C., Sivery, B., Senneville, E., Vincent-Du-Laurier, M., Mouton, Y. Traitement des pneumonies dues aux legionelles, mycoplasmes, chlamydiaes et rickettsies par l'ofloxacine. Pathol. Biol. 37 (1989) 1137\u20131140.","journal-title":"Pathol. Biol."},{"key":"BF01715829_CR35","first-page":"34","volume":"39","author":"Y. Mouton","year":"1989","unstructured":"Mouton, Y., Beuscart, C., Leroy, O., Ajana, F., Charrel, J. Groupe multicentrique: evaluation de la ciprofloxacine versus amoxicilline plus acide clavulanique ou erythromycin pour le traitement empirique des pneumonies communautaires. Pathol. Biol. 39 (1989) 34\u201337.","journal-title":"Pathol. Biol."},{"key":"BF01715829_CR36","unstructured":"Schonwald, S., Petricevie, I., Car, V., Soldo, I., Skerk, V.: Ciprofloxacin applied in treatment of interstitial pneumonias of infectious etiology. In:Berbaka, B. (ed.): Proceedings of the 15th International Congress of Chemotherapy, Istanbul 1987, Abstract no. 1285."},{"key":"BF01715829_CR37","volume-title":"A multicenter, double-blind randomized comparative study of the efficacy and safety of temafloxacin and amoxicillin in the treatment of community acquired pneumonia in hospital patients","author":"C. Carbon","year":"1990","unstructured":"Carbon, C., Leophonte, P., andthe Frech Cooperative Study Group. A multicenter, double-blind randomized comparative study of the efficacy and safety of temafloxacin and amoxicillin in the treatment of community acquired pneumonia in hospital patients. In: Program and Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21\u201324, 1990. American Society for Microbiology, Washington D.C. 1990, Abstract no. 782."},{"key":"BF01715829_CR38","first-page":"291","volume":"20","author":"A. Wynckel","year":"1991","unstructured":"Wynckel, A., Toupance, O., Melin, J. P., David, C., Lavaud, S., Wong, T., Lamiable, D., Chanard, J. Traitement des l\u00e9gionelloses par ofloxacine chez le transplante r\u00e9nal. Presse M\u00e9d. 20 (1991) 291\u2013293.","journal-title":"Presse M\u00e9d."},{"issue":"Suppl. 1","key":"BF01715829_CR39","first-page":"S218","volume":"10","author":"J. H. Winter","year":"1988","unstructured":"Winter, J. H., McCartney, C., Bingham, J., Telfer, M., White, L. O., Fallon, R. J. Ciprofloxacin in the treatment of severe Legionnaire's disease. Rev. Infect. Dis. 10 (Suppl. 1) (1988) S218-S219.","journal-title":"Rev. Infect. Dis."},{"key":"BF01715829_CR40","doi-asserted-by":"crossref","first-page":"128S","DOI":"10.1016\/0002-9343(89)90041-7","volume":"Suppl. 5A","author":"K. E. Unertl","year":"1989","unstructured":"Unertl, K. E., Lemhart, F., Forts, H., Vogler, G., Wilm, V., Ehret, W., Ruckdeschel, G. Brief report: ciprofloxacin in the treatment of legionellosis in criticially ill patients including those cases unresponsive to erythromycin. Am. J. Med. (Suppl. 5A) (1989) 128S-131S.","journal-title":"Am. J. Med."},{"issue":"Suppl. B","key":"BF01715829_CR41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/26.suppl_B.129","volume":"26","author":"E. Dournon","year":"1990","unstructured":"Dournon, E., Mayaud, C., Wolff, M., Schlemmer, B., Samuel, D., Sollet, J. P., Levasseur-Rajagopalan, P. Comparison of the activity of three antibiotic regimens in severe Legonnaire's disease. J. Antimicrob. Chemother. 26 (Suppl. B) (1990) 129\u2013139.","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. 5","key":"BF01715829_CR42","first-page":"991","volume":"11","author":"F. Jambon","year":"1989","unstructured":"Jambon, F., Jonquet, O., Reynes, J., Bertrand, D. Use of pefloxacin in the treatment of rickettsiosis and coxiellosis. Rev. Infect. Dis. 11 (Suppl. 5) (1989) 991.","journal-title":"Rev. Infect. Dis."},{"key":"BF01715829_CR43","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/0002-9343(90)90212-V","volume":"89","author":"B. A. Lipsky","year":"1990","unstructured":"Lipsky, B. A., Tack, K. J., Kuo, C. C., Wang, S. P., Grayston, J. T. Ofloxacin treatment ofChlamydia pneumoniae (strain TWAR) lower respiratory tract infections. Am. J. Med. 89 (1990) 722\u2013724.","journal-title":"Am. J. Med."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01715829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01715829\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01715829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T13:04:10Z","timestamp":1557320650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01715829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,7]]},"references-count":43,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[1991,7]]}},"alternative-id":["BF01715829"],"URL":"https:\/\/doi.org\/10.1007\/bf01715829","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,7]]}}}